B. Freilich
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Liver Diseases and Immunity
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Epidemiology 17
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 6
- Hepatology 17
- Hepatitis C virus research 14
- Co-authors
- Stephen A. Harrison (4 shared papers)Peter Ruane (4 shared papers)Tim Rolph (2 shared papers)Cynthia Behling (3 shared papers)Erik J. Tillman (2 shared papers)Rashmee Patil (3 shared papers)Guy Neff (3 shared papers)Chen Hu (2 shared papers)
- Journals
- Journal of Hepatology (15 papers)Gastroenterology (3 papers)Hepatology (2 papers)Journal of Clinical Oncology (2 papers)The Oncologist (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
B. Freilich
30 papers receiving 1.1k citations
B. Freilich's Hit Papers
Peers
Comparison fields: 5 of 66
- Hepatology 431
- Epidemiology 679
- Endocrinology, Diabetes and Metabolism 195
- Cell Biology 92
- Molecular Biology 296
Countries citing papers authored by B. Freilich
This map shows the geographic impact of B. Freilich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Freilich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Freilich more than expected).
Fields of papers citing papers by B. Freilich
This network shows the impact of papers produced by B. Freilich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Freilich. The network helps show where B. Freilich may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Freilich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial Hit paper breakdown → | 2021 | 271 |
| 2 | 2019 | 138 | |
| 3 | 2018 | 107 | |
| 4 | 2018 | 93 | |
| 5 | 2022 | 75 | |
| 6 | 2023 | 67 | |
| 7 | 2008 | 60 | |
| 8 | 2012 | 55 | |
| 9 | 2016 | 51 | |
| 10 | 2015 | 50 | |
| 11 | 2011 | 37 | |
| 12 | 2015 | 28 | |
| 13 | 2006 | 14 | |
| 14 | 2006 | 13 | |
| 15 | 2015 | 11 | |
| 16 | 2019 | 9 | |
| 17 | 2007 | 7 | |
| 18 | 2008 | 7 | |
| 19 | 1994 | 6 | |
| 20 | 2006 | 4 |
About B. Freilich
B. Freilich is a scholar working on Epidemiology, Hepatology, Rheumatology, Pulmonary and Respiratory Medicine and Surgery, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (6 papers), Systemic Lupus Erythematosus Research (3 papers), HIV/AIDS drug development and treatment (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Hepatology (431 citations), Epidemiology (679 citations), Endocrinology, Diabetes and Metabolism (195 citations), Cell Biology (92 citations) and Molecular Biology (296 citations). B. Freilich has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Stephen A. Harrison, Peter Ruane, Tim Rolph, Cynthia Behling, Erik J. Tillman, Rashmee Patil, Guy Neff, Chen Hu, Kitty Yale and Brittany de Temple. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, Journal of Clinical Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.